CIK 0001010086
- Accelerated filer
SIGA TECHNOLOGIES INC
Sign in to watch- Ticker
- SIGA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 133864870
- Phone
- +1 212-672-9100
- Business address
- 31 EAST 62ND STREET, NEW YORK, NY, 10065
- Former names
- SIGA PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-01-03 | ROSE ERIC A MD Chief Executive Officer | Exercise or conversion | +66,666 | 462,753 | ||
| 2014-01-03 | ROSE ERIC A MD Chief Executive Officer | Shares withheld for taxes | −29,033 | $3.35 | $97K | 433,720 |
| 2014-01-03 | ROSE ERIC A MD Chief Executive Officer | Purchase | +0 | 13,300 | ||
| 2014-01-03 | ROSE ERIC A MD Chief Executive Officer | Exercise or conversion · Restricted Stock Units | −66,666 | 133,334 | ||
| 2014-01-03 | ROSE ERIC A MD Chief Executive Officer | Grant or award · Restricted Stock Units | +200,000 | 200,000 | ||
| 2014-01-03 | Haynes William J II Executive VP & General Counsel | Exercise or conversion | +25,000 | 25,000 | ||
| 2014-01-03 | Haynes William J II Executive VP & General Counsel | Shares withheld for taxes | −11,063 | $3.35 | $37K | 13,937 |
| 2014-01-03 | Haynes William J II Executive VP & General Counsel | Exercise or conversion · Restricted Stock Units | −25,000 | 50,000 | ||
| 2014-01-03 | Haynes William J II Executive VP & General Counsel | Grant or award · Restricted Stock Units | +75,000 | 75,000 | ||
| 2013-12-31 | Hruby Dennis E VP & Chief Scientific Officer | Other disposition | −40,799 | 56,545 | ||
| 2013-12-17 | Hruby Dennis E VP & Chief Scientific Officer | Exercise or conversion | +150,000 | $1.40 | $210K | 165,747 |
| 2013-12-17 | Hruby Dennis E VP & Chief Scientific Officer | Shares withheld for taxes | −68,403 | $3.07 | $210K | 97,344 |
| 2013-12-17 | Hruby Dennis E VP & Chief Scientific Officer | Exercise or conversion · Stock Option (Right to Buy) | −150,000 | 150,000 | ||
| 2013-09-17 | BAYER MICHAEL J Director | Purchase | +8,284 | $3.59 | $30K | 13,960 |
| 2013-09-17 | BAYER MICHAEL J Director | Purchase | +9,324 | $3.59 | $33K | 15,000 |
| 2013-09-16 | BAYER MICHAEL J Director | Purchase | +5,676 | $3.57 | $20K | 5,676 |
| 2013-09-13 | BAYER MICHAEL J Director | Sale | −3,378 | $3.53 | $12K | 0 |
| 2013-09-12 | BAYER MICHAEL J Director | Sale | −11,622 | $3.55 | $41K | 3,378 |
| 2013-05-30 | SLOVIN BRUCE Director | Sale | −15,000 | $3.83 | $58K | 105,000 |
| 2013-05-24 | Marshall Joseph W III Director | Purchase | +7,000 | $3.59 | $25K | 30,000 |
Page 34 of 38 · 760 trades